Biomind Labs Stock Buy Hold or Sell Recommendation

BMNDF Stock  USD 0.11  0.00  0.00%   
Roughly 55% of Biomind Labs' stockholders are presently thinking to get in. The analysis of overall sentiment of trading Biomind Labs pink sheet suggests that some investors are interested at this time. The current market sentiment, together with Biomind Labs' historical and current headlines, can help investors time the market. In addition, many technical investors use Biomind Labs stock news signals to limit their universe of possible portfolio assets.

Comfort Level 55

 Impartial

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Biomind Labs' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Biomind Labs.
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Biomind Labs is 'Hold'. Macroaxis provides Biomind Labs buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding BMNDF positions.
  

Execute Biomind Labs Buy or Sell Advice

The Biomind recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Biomind Labs. Macroaxis does not own or have any residual interests in Biomind Labs or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Biomind Labs' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Biomind LabsBuy Biomind Labs
Sell

Market Performance

FairDetails

Volatility

Out of controlDetails

Hype Condition

StaleDetails

Current Valuation

OvervaluedDetails

Odds Of Distress

ModerateDetails

Economic Sensitivity

Hyperactively responds to market trendsDetails

Analyst Consensus

Not AvailableDetails

Reporting Quality (M-Score)

InapplicableDetails
For the selected time horizon Biomind Labs has a Mean Deviation of 13.68, Standard Deviation of 54.56 and Variance of 2976.47
We provide trade advice to complement the prevailing expert consensus on Biomind Labs. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Biomind Labs is not overpriced, please confirm all Biomind Labs fundamentals, including its cash and equivalents and the relationship between the debt to equity and market capitalization . As Biomind Labs appears to be a penny stock we also recommend to validate its total debt numbers.

Biomind Labs Trading Alerts and Improvement Suggestions

Biomind Labs is way too risky over 90 days horizon
Biomind Labs has some characteristics of a very speculative penny stock
Biomind Labs appears to be risky and price may revert if volatility continues
Biomind Labs has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (4.33 M) with profit before overhead, payroll, taxes, and interest of 0.
Biomind Labs has accumulated about 1.61 M in cash with (2.12 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02.
Roughly 90.0% of the company shares are held by company insiders

Biomind Labs Returns Distribution Density

The distribution of Biomind Labs' historical returns is an attempt to chart the uncertainty of Biomind Labs' future price movements. The chart of the probability distribution of Biomind Labs daily returns describes the distribution of returns around its average expected value. We use Biomind Labs price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Biomind Labs returns is essential to provide solid investment advice for Biomind Labs.
Mean Return
7.12
Value At Risk
0.00
Potential Upside
0.00
Standard Deviation
55.50
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Biomind Labs historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Biomind Labs Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Biomind Labs or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Biomind Labs' price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Biomind pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over Dow Jones
6.82
β
Beta against Dow Jones4.25
σ
Overall volatility
56.29
Ir
Information ratio 0.13

Biomind Labs Volatility Alert

Biomind Labs is displaying above-average volatility over the selected time horizon. Biomind Labs is a potential penny stock. Although Biomind Labs may be in fact a good instrument to invest, many penny pink sheets are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Biomind Labs. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Biomind instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.

Biomind Labs Fundamentals Vs Peers

Comparing Biomind Labs' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Biomind Labs' direct or indirect competition across all of the common fundamentals between Biomind Labs and the related equities. This way, we can detect undervalued stocks with similar characteristics as Biomind Labs or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Biomind Labs' fundamental indicators could also be used in its relative valuation, which is a method of valuing Biomind Labs by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Biomind Labs to competition
FundamentalsBiomind LabsPeer Average
Return On Equity-5.72-0.31
Return On Asset-2.59-0.14
Current Valuation39.1 M16.62 B
Shares Outstanding74.76 M571.82 M
Shares Owned By Insiders90.07 %10.09 %
Price To Book143.15 X9.51 X
EBITDA(4.3 M)3.9 B
Net Income(4.33 M)570.98 M
Cash And Equivalents1.61 M2.7 B
Cash Per Share0.02 X5.01 X
Total Debt39.44 K5.32 B
Debt To Equity0.02 %48.70 %
Current Ratio17.05 X2.16 X
Book Value Per Share0.02 X1.93 K
Cash Flow From Operations(2.12 M)971.22 M
Earnings Per Share(0.07) X3.12 X
Number Of Employees918.84 K
Market Capitalization49.95 M19.03 B
Total Asset2.53 M29.47 B
Net Asset2.53 M

Biomind Labs Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Biomind . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Biomind Labs Buy or Sell Advice

When is the right time to buy or sell Biomind Labs? Buying financial instruments such as Biomind Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Biomind Labs in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Heavy Metals Thematic Idea Now

Heavy Metals
Heavy Metals Theme
Companies involved in mining, production, and distribution of various industrial metals and minerals. The Heavy Metals theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Heavy Metals Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Biomind Pink Sheet

Biomind Labs financial ratios help investors to determine whether Biomind Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biomind with respect to the benefits of owning Biomind Labs security.